Image by Michal Jarmoluk on Pixabay
GenScript Launches Assay
GenScript has launched an assay for the detection of the coronavirus. The Piscataway, NJ-based company said its test is a fast, one-step 2019-nCoV quantitative reverse-transcription polymerase chain reaction (qRT-PCR) detection assay, or reagent. GenScript's 2019-nCoV qRT-PCR detection assay is an enhancement on the World Health Organization's monoplex protocol published in January after the virus was identified in Wuhan city in the Hubei Province of China.
GenScript said it had developed a multiplex protocol that can detect two to three genes in one reaction, therefore accelerating the detection time of all three genes associated with the virus. GenScript's production facility also has ISO13485 certification for oligo production to address the needs of the molecular diagnostic companies interested in developing kits for approval in the U.S. market.